Back to results
US 12,351,812 B2Granted
Recombinant oncolytic virus
AssigneeGeorgia State University Research Foundation, Inc.
InventorMing Luo
Life of this patent
Estimating the term…
Abstract
Recombinant viral vectors are disclosed that contain a nucleic acid encoding a Second Mitochondria-derived Activator of Caspases (Smac) protein inserted within an RNA virus genome, wherein the Smac protein specifically binds to at least a portion of an Inhibitor of Apoptosis Protein (IAP). Also disclosed are methods of treating cancer using the disclosed vectors.
Claims10
A recombinant viral vector comprising a nucleic acid encoding a Second Mitochondria-derived Activator of Caspases (SMAC) protein inserted within the genome of a vesicular stomatitis virus (VSV),
- wherein the SMAC protein consists of the amino acid sequence SEQ ID NO:1 or 2, or a conservative variant thereof having an IAP-binding motif comprising the amino acid sequence SEQ ID NO:3 and that specifically binds to at least a portion of an Inhibitor of Apoptosis Protein (IAP),
- wherein the virus genome comprises at least a nucleoprotein (N or NP) gene, a phosphoprotein (P) gene, a glycoprotein (G) gene, and a matrix protein (M) gene,
- wherein the G gene encodes a modified G protein that consists of the amino acid sequence SEQ ID NO:5 with a peptide sequence six amino acids or less comprising an RGD sequence inserted after amino acid position 190 of SEQ ID NO:5, and
- wherein the nucleic acid encoding SMAC protein is inserted between the M gene and glycoprotein (G) gene.
1 more element
Dependencies are inferred from the claim text.